Registration Info

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Registration Fee

Practicing Healthcare Professionals: $129

Non-Clinicians / Medical Office Support Staff / Industry Participants

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend PAINWeekEnd.


Unfortunately, we do not have discounts available on hotel rooms. Please contact the hotel directly should you require accommodations.

Jacksonville Marriott
4670 Salisbury Rd.
Jacksonville, FL 32256

View hotel website >>


Get Directions using Google Maps


Faculty and courses are subject to change. Please refer to the online schedule below for the most recent course descriptions.

To view the schedule below, click on the + sign next to the day of the conference to expand the conference agenda. Click on the + signs within the agenda to view the course description, UAN number, and AANP pharmacology credits.

*not certified for credit

Saturday, June 1, 2019


    Coffee will be served.

  • Pain Pathways Made Simple

    In order to successfully clinically manage pain, it is essential to begin with an understanding of the underlying mechanisms responsible for its generation. A skillful approach based upon better knowledge concerning the anatomical structures, pathways, and events that result in pain is more likely to lead to effective clinical management of pain. The discussion will include an overview of medication classes typically considered for pain and the pathways they affect.

    • UAN: 0530-0000-19-041-L01-P
    • AANP Rx Hours: 0.00

    Breakfast will be served.

    Sponsored by Legally Mine.


  • Relax, All Antispasmodics Are the Same….Right?

    Antispasmodics are commonly used in managing pain from muscle spasms, cramping, and sometimes hiccups, but they aren’t a one-size-fits-all medication. Certain antispasmodics are for smooth muscle, others are for skeletal muscle. Some are more sedating. The aim of this session is to provide a high level review of the different classes and types of antispasmodics and their place in therapy. The discussion will include pharmacokinetic profiles, side effects, and dosing pearls for the different muscle relaxers. Participants should leave the presentation with a better understanding of the appropriate place of antispasmodics in therapy and be more “relaxed” when choosing one, knowing that they are customizing their patient’s care by matching the symptom to the appropriate medication.

    • UAN: 0530-0000-19-074-L01-P
    • AANP Rx Hours: 0.80
  • Osteoarthritis Pain: Past, Present, and Future

    Pain related to osteoarthritis is extremely common, affecting a very large segment of the adult population. For years, many therapeutic approaches have been used with variable degrees of success. Over time, however, we have learned that some commonly used therapies may be ineffective or, worse yet, can lead to significant harm. In this course, available management methods, including oral agents, topical and physical agents, orthotics, and various injectable agents will be discussed, emphasizing existing and emerging medical evidence with proliferant/reparative agents and support of their use. Basic concepts regarding surgical options and their evidence will also be discussed in order for primary and specialty care providers in the audience to better use these treatment options, and know when to refer and how to educate their patients more effectively.

    • UAN: 0530-0000-19-073-L01-P
    • AANP Rx Hours: 0.30



    Lunch will be served.

    Sponsored by SCILEX.

  • Ketamine: Not Just For Horses

    Ketamine is an n-methyl-d-aspartate (nmda) receptor antagonist and is both water and lipid soluble. These unique pharmacokinetic properties make ketamine a useful analgesic in that it can be given via multiple routes of administration and can add a different pathway for pain treatment in difficult or refractory pain cases. The goal of this presentation is to familiarize attendees with an additional adjuvant pain medication for use in refractory pain. After some background information is presented, a case based approach will be used to demonstrate patient identification, dosing strategies, routes of administration, and side-effect management.  The presentation will conclude with methods for developing a ketamine protocol.

    • UAN: 0530-0000-19-091-L01-P
    • AANP Rx Hours: 0.30


    Refreshments will be served.

    Sponsored by Emergent BioSolutions.

  • Clinical Pearls: Unraveling the Secrets of Imaging Studies

    Diagnostic testing is an integral component for the differential diagnosis. In routine clinical practice there has been a tendency for clinical examinations to become more cursory, largely influenced by increasing demands of time and patient expectations of technological advances. The end result may arguably lead to an overreliance on technology for basic clinical diagnosis. The purpose of this session is 2-fold. It is meant to provide a review and, for some, an introduction to basic structural and functional studies used for the diagnosis of pain related problems. Attention will also be given to the limitations of such studies and the importance of establishing clinical relevance to their findings. Factors that adversely affect clinical management potentially resulting in failed treatment will be discussed as well as best practices when utilizing such studies to help enhance clinical outcomes for treatment.

    • UAN: 0530-0000-19-039-L01-P
    • AANP Rx Hours: 0.00
  • Diabetic Peripheral Neuropathic Pain: Evaluating Treatment Options

    According to estimates from the Centers for Disease Control and Prevention, 29.1 million people (close to 10% of the US population) have diabetes and 30% to 50% of them eventually develop diabetic peripheral neuropathy, often with pain. Neuropathic pain due to diabetes is a commonly encountered chronic problem that has increased in frequency as the obese and diabetic population continues to increase. Many pharmacologic approaches including various algorithms are used to treat painful diabetic neuropathy; however, the effectiveness of many such medications is questionable. New evidence, including recent recommendations from the American Academy of Neurology, will be compared and contrasted with a prior systematic review and guideline, published in 2011. Agents and approaches with more recent evidence will be discussed in order to update knowledge of participants and assist them to better manage this disabling ailment.

    • UAN: 0530-0000-19-054-L01-P
    • AANP Rx Hours: 0.50


To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon "Brain Food" time slots in the schedule. There is NO ADDITIONAL CHARGE to attend these program sessions!